z-logo
open-access-imgOpen Access
STANDARD OPERATIVE PROCEDURE FOR FRORMULATION OF MORINDA CIT-RIFOLIA L. GRANULES
Author(s) -
Krithika R Aithal,
Sumanth Shenoy H,
Subrahmanya Padyanna
Publication year - 2020
Publication title -
international ayurvedic medical journal
Language(s) - English
Resource type - Journals
ISSN - 2320-5091
DOI - 10.46607/iamjp040432020
Subject(s) - morinda , traditional medicine , medicine , shelf life , antispasmodic , palatability , pharmacology , chemistry , food science , pathology
The science of life is the basic meaning of Ayurveda. As like any other medical system, success of treatment also depends upon quality of medicine prescribed to the patient. Standardization of Ayurvedic drugs at various levels starting from the selection and collection of raw materials till the final product. It is essential to produce a safe and efficacious formulation for the needy patients. Preparation of granules is one of modified form of Ghana (solid preparation of herbal extract) and Khanda Kalpana (Solid preparation simi-lar to granules). Present study has elaborated formulation of noni granules with analytical studies conduct-ed as mentioned in Ayurvedic Pharmacopia of India. Noni is the common name of the drug Morinda citri-folia L. and is also called as Indian mulberry. It has been used widely as a complementary and alternative therapy owing to its potent antioxidant property and proven health benefits. As every part of noni plant is useful, it is widely used as Antioxidant, Immunostimulant, Immunomodulant, Analgesic, Antiarthritic, An-tipyretic, Antirheumatic, Antitumours, Antispasmodic, Depurative, Diuretic, Antiemetic, Hypotensive, Fungiscide, Laxative, Litholytic, Sedative, Stomachic. The aim of the study is to form noni granules from noni fruit juice by adding adjuvants in order to improve its palatability and shelf life. The prepared gran-ules have shown good palatability and increased shelf life

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here